Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Aldeyra Therapeutics, Inc. Common Stock · ALDX

ALDXNASDAQCommon stockCurrentCIK 1341235Updated Nov 18, 2026

Company: Aldeyra Therapeutics, Inc. →

Name history
Aldexa Therapeutics, Inc. · through Mar 4, 2014Neuron Systems Inc · through Aug 1, 2008

ALDX price & chart

Provider market data

Loading TradingView…

NASDAQ:ALDX on TradingView ↗

TradingView · Data may be delayed

About the company

Aldeyra Therapeutics is a biotechnology company devoted to discovering innovative therapies designed to treat immune-mediated diseases. Our approach is to develop pharmaceuticals that modulate protein systems, instead of directly inhibiting or activating single protein targets, with the goal of optimizing multiple pathways at once while minimizing toxicity. Our product candidates include RASP (reactive aldehyde species) modulators ADX-248 and chemically related molecules for the potential treatment of systemic and retinal immune-mediated diseases. Our late-stage product candidates are reproxalap, a RASP modulator for the potential treatment of dry eye disease and allergic conjunctivitis, and ADX-2191, a novel formulation of intravitreal methotrexate for the potential treatment of primary vitreoretinal lymphoma.

8-K · 2026-09-29 · 0001193125-26-405954

Company description from the cited filing.

In the news

Seeking Alpha

Financials

FY 2025 · USD
Revenue— · FY 2025
Net income-33,846,661USD · FY 2025
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

Operating income-35,265,206USD · FY 2025
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

Diluted EPS-0.56USD per share · FY 2025
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD77,801,012
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

117,319,352
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

47,540,559
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

84,962,888
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

126,043,834
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

66,483,081
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

93,195,717
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

141,301,892
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

72,059,317
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

104,606,694
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

148,326,911
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

181,291,657
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Property, Plant and Equipment, NetUSD—1,360
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

20,544
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

—2,720
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

——4,079
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

—0
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

5,764
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

19,279
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD59,340,599
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

68,120,029
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

—41,241,269
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

71,029,723
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

—50,350,617
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

102,491,900
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

70,041,254
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

54,527,092
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

—144,419,364
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Assets, CurrentUSD77,460,035
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

116,720,763
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

47,378,906
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

84,558,228
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

125,649,519
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

66,273,819
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

92,728,775
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

140,845,946
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

71,783,456
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

104,072,478
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

147,810,333
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

181,023,113
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD2,162,696
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

3,976,564
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

2,289,120
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

2,638,589
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

5,317,836
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

1,271,514
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

2,670,698
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

7,808,596
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

1,742,202
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

2,921,206
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

4,987,317
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

6,722,229
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD340,977
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

329,968
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

141,109
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

404,660
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

391,595
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

209,262
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

466,942
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

451,867
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

275,861
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

266,955
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

510,814
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

249,265
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD28,556,469
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

32,223,648
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

9,655,256
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

29,674,746
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

27,733,495
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

24,326,289
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

29,597,140
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

27,882,451
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

27,808,927
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

33,601,823
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

28,531,881
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

30,283,628
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Stockholders’ equity:
Preferred Stock, Value, IssuedUSD0
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

0
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

0
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

0
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

0
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

0
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

0
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

0
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

0
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

0
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

0
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

0
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Common Stock, Value, IssuedUSD60,163
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

59,550
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

60,321
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

60,046
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

59,415
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

60,321
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

60,046
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

59,415
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

60,163
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

59,648
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

59,196
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

58,560
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-477,495,746
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

-434,301,825
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

-492,860,145
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

-469,807,405
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

-419,188,842
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

-487,409,872
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

-460,040,093
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

-402,341,270
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

-483,957,253
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

-450,110,592
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

-394,259,148
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

-356,716,638
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD815
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

66,540
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

—-10,995
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

-9,658
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

—1,598
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

-3,029
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

0
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

37,442
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

0
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

-103,938
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD49,244,543
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

85,095,704
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2024-09-30

37,885,303
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

55,288,142
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2025-06-30

98,310,339
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2024-06-30

42,156,792
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

63,598,577
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2025-03-31

113,419,441
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2024-03-31

44,250,390
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

71,004,871
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

119,795,030
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

151,008,029
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Additional Paid in Capital, Common StockUSD526,679,311
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

519,271,439
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

530,685,127
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

525,046,496
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

517,449,424
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

529,506,343
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

523,577,026
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

515,704,325
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

528,147,480
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

521,018,373
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

513,994,982
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

507,770,045
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Liabilities and EquityUSD77,801,012
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

117,319,352
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

47,540,559
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

84,962,888
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

126,043,834
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

66,483,081
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

93,195,717
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

141,301,892
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

72,059,317
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

104,606,694
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

148,326,911
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

181,291,657
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD28,483,933
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

17,153,414
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

9,655,256
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

29,531,299
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

27,594,602
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

24,326,289
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

14,285,842
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

21,676,437
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

27,808,927
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

18,601,823
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

22,260,250
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

15,360,538
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Operating Lease, Liability, CurrentUSD271,948
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

263,241
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

143,447
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

263,551
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

255,039
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

212,769
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

255,342
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

247,021
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

280,537
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

271,631
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

239,183
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

249,265
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Accounts Payable, CurrentUSD13,423
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

186,919
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

137,476
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

1,455,271
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

254,434
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

141,356
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

346,146
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

280,299
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

158,461
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

180,453
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

1,338,057
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

133,625
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD72,536
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

70,234
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

0
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

143,447
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

138,893
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

0
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

212,769
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

206,014
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

0
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

0
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

271,631
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

0
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD6,999,297
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

10,423,297
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

3,374,333
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

6,663,580
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

5,842,802
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

2,672,164
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

7,684,354
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

5,944,419
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

6,120,297
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

12,118,367
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

5,536,464
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

14,065,885
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Deferred Revenue, CurrentUSD—6,000,000
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

——6,000,000
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

———6,000,000
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

6,000,000
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

——
Long-term Debt, Excluding Current Maturities—
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

—
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

——
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

—
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

—
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

—
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

—
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

—
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

—
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

—
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

—
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Long-term Debt, Current MaturitiesUSD15,199,265
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

279,957
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

0
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

15,148,897
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

15,242,327
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

15,300,000
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

0
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

15,204,698
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

15,249,632
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

31,372
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

15,146,546
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

911,763
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Long-term Debt, Excluding Current MaturitiesUSD0
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

15,000,000
Source

10-Q · 2024-11-07 · 0000950170-24-123248

As of 2024-09-30

—0
Source

10-Q · 2025-08-07 · 0000950170-25-104971

As of 2025-06-30

0
Source

10-Q · 2024-08-01 · 0000950170-24-089238

As of 2024-06-30

0
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

15,098,529
Source

10-Q · 2025-05-14 · 0000950170-25-071602

As of 2025-03-31

0
Source

10-Q · 2024-05-02 · 0000950170-24-052056

As of 2024-03-31

0
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

15,000,000
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

0
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

14,923,090
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——————-3,452,619
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

-9,929,501
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

-33,846,661
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

-55,851,444
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

-37,542,510
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

-62,024,636
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Share-based Payment Arrangement, Noncash ExpenseUSD——————-987,554
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

2,224,013
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

6,091,413
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

7,973,499
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

5,752,771
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

8,288,976
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts PayableUSD——————-17,105
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

165,693
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

-21,992
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

-1,157,604
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

1,204,432
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

-886,077
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-5,110,089
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

-12,469,699
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

-33,345,682
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

-43,208,747
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

-30,326,128
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

-56,637,187
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————0
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

7,290,414
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

47,736,288
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

-44,915,755
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

30,000,000
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

-29,954,530
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD——————————0
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

16,317
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Payment, Tax Withholding, Share-based Payment ArrangementUSD—————————0
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

532,951
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

—
Net Cash Provided by (Used in) Financing ActivitiesUSD——————71,140
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

1,002,810
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

1,123,556
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

-171,422
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

-1,270,220
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

1,220,092
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-5,038,949
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

-4,176,475
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

15,514,162
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

-88,295,924
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

-1,596,348
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

-85,371,625
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——59,340,599
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2025-09-30

68,120,029
Source

10-Q · 2025-11-05 · 0001193125-25-266989

As of 2024-09-30

45,089,786
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2026-06-30

41,241,269
Source

10-Q · 2026-08-06 · 0001341235-26-000010

As of 2025-06-30

65,002,305
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2026-03-31

50,350,617
Source

10-Q · 2026-05-07 · 0001341235-26-000006

As of 2025-03-31

70,041,254
Source

10-K · 2026-02-27 · 0001193125-26-083012

As of 2025-12-31

54,527,092
Source

10-K · 2025-02-28 · 0000950170-25-030102

As of 2024-12-31

142,823,016
Source

10-K · 2024-03-07 · 0000950170-24-027933

As of 2023-12-31

144,419,364
Source

10-K · 2023-03-09 · 0000950170-23-006998

As of 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD——————416,250
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

416,250
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

1,688,125
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

1,753,792
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

1,702,188
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

1,338,542
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD——2,580,753
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

3,225,794
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

1,643,000
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

196,564
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

-987,554
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

2,224,013
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

6,091,413
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

7,973,499
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

5,752,771
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

8,288,976
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

DepreciationUSD——————66,599
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

60,912
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

251,993
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

249,623
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

262,780
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

258,707
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——2,570,375
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

3,696,067
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

2,365,993
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

1,663,503
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

1,137,343
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

3,004,135
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

9,602,351
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

11,892,239
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

13,335,364
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

15,373,921
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

1,000
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

InterestExpenseNonoperatingUSD——475,903
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

479,252
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

23
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

470,618
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

468,678
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

483,529
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

1,905,310
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

1,926,241
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

——
Investment Income, InterestUSD——788,694
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

1,503,845
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

400,257
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

872,038
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

562,977
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

981,487
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

3,323,855
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

6,191,829
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

7,323,008
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

2,349,449
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Marketable Securities, Unrealized Gain (Loss)USD————————-100,000
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

100,000
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

100,000
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

—
Net Income (Loss) Attributable to ParentUSD——-7,688,341
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

-15,112,983
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

-5,450,273
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

-9,767,312
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

-3,452,619
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

-9,929,501
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

-33,846,661
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

-55,851,444
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

-37,542,510
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

-62,024,636
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——312,791
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

1,024,593
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

400,234
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

401,420
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

94,299
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

497,958
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

1,418,545
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

4,265,588
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

5,251,573
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

655,351
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD——————72,500
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

67,800
Source

10-Q · 2025-05-14 · 0000950170-25-071602

2025-01-01 to 2025-03-31

300,000
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

300,000
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

300,000
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

200,000
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Proceeds from Issuance of Common StockUSD———————————0
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Proceeds from Stock Options ExercisedUSD——————71,140
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

983,194
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

1,103,940
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

350,279
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

194,129
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

1,123,427
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Operating Income (Loss)USD——-8,001,132
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

-16,137,576
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

-5,850,507
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

-10,168,732
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

-3,546,918
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

-10,427,459
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

-35,265,206
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

-60,117,032
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

-42,794,083
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

-62,679,987
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

1,000
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-7,688,341
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

-15,112,983
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

-5,450,273
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

-9,767,312
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

-3,452,619
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

-9,929,501
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

-33,846,661
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

-55,851,444
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

-37,542,510
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

-62,024,636
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-0.13
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

-0.25
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

-0.09
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

-0.16
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

-0.06
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

-0.17
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

-0.56
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

-0.94
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

-0.64
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

-1.06
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-0.13
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

-0.25
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

-0.09
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

-0.16
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

-0.06
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

-0.17
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

-0.56
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

-0.94
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

-0.64
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

-1.06
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——60,126,850
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

59,530,113
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

60,321,068
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

60,045,530
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

60,319,289
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

59,887,277
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

60,056,557
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

59,484,794
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

58,943,205
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

58,405,897
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——60,126,850
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

59,530,113
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

60,321,068
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

60,045,530
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

60,319,289
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

59,887,277
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

60,056,557
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

59,484,794
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

58,943,205
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

58,405,897
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Interest Expense (non-operating)USD——475,903
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

479,252
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

23
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

470,618
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

468,678
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

483,529
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

1,905,310
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

1,926,241
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

——
Additional Financial Items
General and Administrative ExpenseUSD——2,570,375
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

3,696,067
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

2,365,993
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

1,663,503
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

1,137,343
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

3,004,135
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

9,602,351
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

11,892,239
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

13,335,364
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

15,373,921
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Income (Loss) Attributable to Parent, before TaxUSD————————33,846,661
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

———
Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD————————33,846,661
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

———
Interest ExpenseUSD——————————2,071,435
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

1,694,098
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Investment Income, InterestUSD——788,694
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

1,503,845
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

400,257
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

872,038
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

562,977
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

981,487
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

3,323,855
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

6,191,829
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

7,323,008
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

2,349,449
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——312,791
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

1,024,593
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

400,234
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

401,420
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

94,299
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

497,958
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

1,418,545
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

4,265,588
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

5,251,573
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

655,351
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD——————72,500
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

67,800
Source

10-Q · 2025-05-14 · 0000950170-25-071602

2025-01-01 to 2025-03-31

300,000
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

300,000
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

300,000
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

200,000
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD——5,430,757
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2025-07-01 to 2025-09-30

12,441,509
Source

10-Q · 2025-11-05 · 0001193125-25-266989

2024-07-01 to 2024-09-30

3,484,514
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2026-04-01 to 2026-06-30

8,505,229
Source

10-Q · 2026-08-06 · 0001341235-26-000010

2025-04-01 to 2025-06-30

2,409,575
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2026-01-01 to 2026-03-31

7,423,324
Source

10-Q · 2026-05-07 · 0001341235-26-000006

2025-01-01 to 2025-03-31

25,662,855
Source

10-K · 2026-02-27 · 0001193125-26-083012

2025-01-01 to 2025-12-31

48,224,793
Source

10-K · 2025-02-28 · 0000950170-25-030102

2024-01-01 to 2024-12-31

29,458,719
Source

10-K · 2024-03-07 · 0000950170-24-027933

2023-01-01 to 2023-12-31

47,306,066
Source

10-K · 2023-03-09 · 0000950170-23-006998

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

aldx-ex99_1.htm · 8-K · 2026-09-29

Reproxalap for the Potential Treatment of Dry Eye Disease: Regulatory Update CONFERENCE CALL September 29, 2026 Nasdaq: ALDX © Aldeyra Therapeutics, Inc. 2026 Exhibit 99.1 Disclaimers and Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding Aldeyra’s possible or assumed future results of operatio…

8-K · 2026-09-29 · 0001193125-26-405954

Read attachment ↗
aldx-ex99_2.htm · 8-K · 2026-09-29

Exhibit 99.2 News Release Aldeyra Therapeutics Announces Intent to Submit Formal Dispute Resolution Request for Reproxalap to Treat Dry Eye Disease Concord, Mass. September 29, 2026 - Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced intent to submit to the U.S. Food and Drug Administration (FDA) a Formal Dispute Resolution Request (FDRR) for reprox…

8-K · 2026-09-29 · 0001193125-26-405954

Read attachment ↗
aldx-ex99_1.htm · 8-K · 2026-06-10

EX-99.1 2 aldx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Aldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directors Lexington, Mass., June 9, 2026 - Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced the appointment of Darlene Deptula-Hicks to Aldeyra’s board of directors (the Board). “Ms. Deptula-Hicks brings decades of experience …

8-K · 2026-06-10 · 0001193125-26-264514

Read attachment ↗
aldx-ex99_1.htm · 8-K · 2026-05-01

EX-99.1 2 aldx-ex99_1.htm EX-99.1 Innovative Therapeutics for Immune-Mediated Diseases CORPORATE OVERVIEW May 2026 Nasdaq: ALDX © Aldeyra Therapeutics, Inc. 2026 Exhibit 99.1 Disclaimers and Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding Aldeyra’s possible or assumed future results of o…

8-K · 2026-05-01 · 0001193125-26-199157

Read attachment ↗
aldx-ex99_1.htm · 8-K · 2026-03-17

EX-99.1 2 aldx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease Lexington, Mass., March 17, 2026 - Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced receipt of…

8-K · 2026-03-17 · 0001193125-26-109511

Read attachment ↗
aldx-ex99_1.htm · 8-K · 2025-12-16

EX-99.1 2 aldx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 News Release Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease Lexington, Mass. December 15, 2025 - Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that the U.S. Food and Drug Administration (FDA) has extended the…

8-K · 2025-12-16 · 0001193125-25-319638

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.